What’s new
We found a statistically significant correlation between lower M/C ratio
or levels of first spot urinary melatonin-sulfate and the risk of
prostate cancer. Furthermore, we reached the conclusion that patients
with both low PSA levels and M/C ratios beyond 10 ng/mL were much more
exposed to advanced (end-stage) disease and prostate cancer.
Conflict of Interest: There is no conflict of interest in the
present study.
Financial Disclosure: No financial support or funds were used
for the study.
Acknowledgements: none declared